BIOSIMILARS COMPANY PARTNERSHIPS NEWSROOM JOIN US COMPANY POWERFUL PLAYER IN BIOSIMILARS COMPANY OVERVIEW Alvotech is a global biopharmaceutical company dedicated to becoming one of the leaders in the biosimilar monoclonal antibody market. Alvotech is an independent sister company of the international pharmaceuticals company, Alvogen, led by Robert Wessman. The company has six key biosimilar molecules in development and a new state-of-the-art manufacturing plant for development and commercial supply. Alvotech is investing over $500 million in the development of its pipeline and facility. MILLION INVESTMENT 500 MABS IN PIPELINE 6 BIOSMILIARS MARKET DYNAMICS By the year 2020, over $100 billion of biologic pharmaceutical products are expected to lose patent protection and many large monoclonal antibody therapies are coming off patent globally after 2018. Many of these products are among the highest selling drugs in the world today. MARKET TRENDS MEET MANAGEMENT LEADERSHIP TEAM Alvotech’s management team is building a leading biopharmaceutical company. Our organizational structure is effective, flexible and has a proven track record that will enable the company to bring new biopharmaceutical products quickly and safely to market. Robert Wessman is the Chairman and founder of Alvotech and the leadership team is helmed by Dr. Andreas Herrmann. MEET MANAGEMENT IN ICELAND ALVOTECH RUNS ITS FACILITY ON GREEN ENERGY MANUFACTURING CAPABILITIES Alvotech already broke ground for the construction of a new 12,000sqm development and manufacturing site. The site will provide Alvotech with capability and access to a new state-of-the-art, fully vertically integrated biologics manufacturing plant, located in the science park of the University of Iceland in Reykjavik. Iceland offers a favorable environment with a strong regulatory system, low operating costs, a great talent pool, high quality standards and a convenient geographical location between the EU and US that is within easy reach of the rest of the world. READ MORE CONNECT WITH ALVOTECH CONTACT US FOLLOW US TERMS OF USE PRIVACY POLICY TEL: + 41 61 2053910 (SWISS), +354 522 2900 (ICELAND) © 2015 ALVOTECH. ALL RIGHTS RESERVED

BIOSIMILARS COMPANY PARTNERSHIPS NEWSROOM JOIN US JOIN US CURRENT JOB OPENINGS A total of 200 new jobs are expected to be created in connection with the company’s operations over the coming years. Interested candidates can apply for these new Alvotech positions on the company’s website NEW JOBS WILL BE CREATED IN ICELAND 200 JOB OPENINGS Technical Team USP&DSP Controls Team Leader Fill Finish/QC Engineer Risk Manager - Quality Affairs Manufacturing Technician Scientist Microbiology Technical Transfer Manager Technical Project Manager Global Drug Regulatory Affairs Manager CMC WE ALWAYS HAVE ROOM FOR TALENT If you can't find what you are looking for, please send us a general Job Application. We review all Job Applications. SUBMIT RESUME CONNECT WITH ALVOTECH CONTACT US FOLLOW US TERMS OF USE PRIVACY POLICY TEL: + 41 61 2053910 (SWISS), +354 522 2900 (ICELAND) © 2015 ALVOTECH. ALL RIGHTS RESERVED